Doramapimod HCl is the salt form of Doramapimod, a member of the N-pyrazole-N-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB -796 has entered clinical trials for the treatment of autoimmune diseases.
Molekulargewicht:
564.13
CAS Nummer:
[1283526-53-3]
Formel:
C31H38ClN5O3
Target-Kategorie:
Others|||Raf|||Autophagy|||p38 MAPK
T71058
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten